Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis

Tuberculosis (TB) still tops the list of global health burdens even after COVID-19. However, it will sooner transcend the current pandemic due to the prevailing risk of reactivation of latent TB in immunocompromised individuals. The indiscriminate misuse and overuse of antibiotics have resulted in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pahuja, Isha, Verma, Akanksha, Ghoshal, Antara, Mukhopadhyay, Suparba, Kumari, Anjna, Shaji, Aishwarya, Chaturvedi, Shivam, Dwivedi, Ved Prakash, Bhaskar, Ashima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434282/
https://www.ncbi.nlm.nih.gov/pubmed/37272833
http://dx.doi.org/10.1128/spectrum.00858-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434282/
https://www.ncbi.nlm.nih.gov/pubmed/37272833
http://dx.doi.org/10.1128/spectrum.00858-23

Ejemplares similares